Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Stratification for Hospital-Acquired Venous Thromboembolism in Medical Patients: a Prospective Cohort Study

NCT04439383 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT04439383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04439383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Stratification for Hospital-Acquired Venous Thromboembolism in Medical Patients: a Prospective Cohort Study
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Completed
Start date
June 22, 2020
Completion date
April 1, 2022
Enrollment
1,353 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, embolism and thrombosis, hospital acquired condition, mobility limitation, pulmonary embolism, venous thromboembolism, venous thromboses